Skip to main content
Clinical Trials/CTRI/2023/03/050468
CTRI/2023/03/050468
Completed
未知

A COMPARATIVE STUDY OF SAFETY AND EFFICACY OF INTRAVENOUS CARBETOCIN VERSUS INTRAMUSCULAR CARBETOCIN INPREVENTION OF POSTPARTUM HEMORRHAGE DURING VAGINAL DELIVERY - A randomized parallel group trial.

DR SWATI TALWADE0 sites134 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Sponsor
DR SWATI TALWADE
Enrollment
134
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
DR SWATI TALWADE

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient consenting for study .
  • 2\.Term pregnancy (37 – 42 weeks of gestation) Expected to delivery vaginally

Exclusion Criteria

  • 1\.Elective cesarean section
  • 2\.Have known allergies to Carbetocin, other Oxytocin homologs or excipients in the medicinal products used in the trial;
  • 3\. Have cardiovascular disorders
  • 4\. Hypertensive disorders
  • 5\. Have hepatic or renal disease
  • 6\. Have epilepsy
  • 7\. Women with coagulopathies
  • 8\. Women having known conditions predisposing to atonic PPH like hydramnios,multiple gestations, and prolonged labor etc.
  • 9\.Are not willing to give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials